Despite never being mutated, the intracellular kinase BTK acts as a signaling hub for CLL cells, transducing pro-survival and pro-adhesive signals from B-cell receptors and chemokine receptors. This evidence concerns the gene BTK and B-cell chronic lymphocytic leukemia.